GlassScriptPrepare for your visit
Kelli Landrum
Family · Kenai, AK · NPI 1437526894
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$4,182.79
in general payments reported to CMS, 2019-2025 · $1,686 in 2025
The $1,686 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 6 by amount.
- Abbott Laboratories $595.48
- Astrazeneca Pharmaceuticals LP $548.27
- Abbvie INC. $494.37
- Axsome Therapeutics, INC. $277.23
- Idorsia Pharmaceuticals US INC $248.97
- Merck Sharp & Dohme LLC $232.33
Drugs and devices associated with these payments
Freestyle Libre 3 Vraylar Verquvo Farxiga Auvelity Airsupra Quviviq Xifaxan Veozah Repatha Ibsrela Arexvy
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Kelli Landrum listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10944623/kelli-landrum